Flagship explainer
What drives ADAPTIVE BIOTECHNOLOGIES CORPORATION’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$59.5M | FY2025 |
| |
| Income before tax | −$59.5M | FY2025 |
|
| Operating income | −$57.1M | FY2025 |
|
| $277M | FY2025 |
| |
| Ending assets | $513M | FY2025 |
|
| Beginning assets | $539M | FY2024 |
|
| $219M | FY2025 |
| |
| $203M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-076902